Hot Pursuit     18-May-24
Glenmark Pharmaceuticals Ltd up for third straight session
Glenmark Pharmaceuticals Ltd is quoting at Rs 1042.45, up 2.25% on the day as on 12:48 IST on the NSE. The stock is up 66.98% in last one year as compared to a 23.61% jump in NIFTY and a 57.6% jump in the Nifty Pharma index.

Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quoting at Rs 1042.45, up 2.25% on the day as on 12:48 IST on the NSE. The benchmark NIFTY is up around 0.16% on the day, quoting at 22502. The Sensex is at 74005.94, up 0.12%. Glenmark Pharmaceuticals Ltd has gained around 1.56% in last one month.

Meanwhile, Nifty Pharma index of which Glenmark Pharmaceuticals Ltd is a constituent, has gained around 3.82% in last one month and is currently quoting at 18981.6, up 0.67% on the day. The volume in the stock stood at 94679 shares today, compared to the daily average of 5.87 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 1046.5, up 2.34% on the day. Glenmark Pharmaceuticals Ltd is up 66.98% in last one year as compared to a 23.61% jump in NIFTY and a 57.6% jump in the Nifty Pharma index.

The PE of the stock is 27.34 based on TTM earnings ending December 23.

Previous News
  Glenmark Pharmaceuticals Ltd spurts 1.23%, up for five straight sessions
 ( Hot Pursuit - 29-May-24   13:00 )
  Volumes spurt at ZF Commercial Vehicle Control System India Ltd counter
 ( Hot Pursuit - 27-May-24   14:30 )
  Market hits new record high; private bank shares rally for 3rd day
 ( Market Commentary - Mid-Session 27-May-24   12:42 )
  Glenmark Pharma net loss widens to Rs 1,239 cr in Q4 FY24
 ( Hot Pursuit - 27-May-24   11:12 )
  Volumes spurt at Torrent Pharmaceuticals Ltd counter
 ( Hot Pursuit - 27-May-24   11:00 )
  Board of Glenmark Pharmaceuticals recommends final dividend
 ( Corporate News - 25-May-24   10:20 )
  Glenmark Pharmaceuticals reports consolidated net loss of Rs 1218.28 crore in the March 2024 quarter
 ( Results - Announcements 25-May-24   07:43 )
  Glenmark Pharma to commercialize BeiGene's oncology medicines in India
 ( Hot Pursuit - 21-May-24   10:05 )
  Glenmark enters into exclusive marketing and distribution agreement with BeiGene
 ( Corporate News - 21-May-24   08:53 )
  Glenmark Pharmaceuticals Ltd up for third straight session
 ( Hot Pursuit - 18-May-24   13:05 )
  Glenmark receives USFDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution
 ( Corporate News - 17-May-24   09:05 )
Other Stories
  Atul Auto's sales in May 2024 rises more than 2x to 2,331 units
  01-Jun-24   16:56
  TVS Motor total sales climb 12% YoY in May’24
  01-Jun-24   16:29
  Inox Wind to raise Rs 1,000 crore Via NCPRPS
  01-Jun-24   16:01
  REC board OKs to raise upto Rs 1.45 lakh crore via private placement
  01-Jun-24   15:35
  Tata Motors total sales rises 2% YoY in May'24
  01-Jun-24   14:57
  Escorts Kubota sells 8,612 tractors in May 2024; construction equipment sales up 3.3% YoY
  01-Jun-24   14:56
  Maruti Suzuki total sales drop to 174,551 units in May’24
  01-Jun-24   14:50
  M&M total sales rises 17% YoY to 71,682 units in May’24
  01-Jun-24   12:53
  CIL's coal production rises 7.5% YoY in May'24; offtake at 68.2 MT
  01-Jun-24   12:17
  Adani Ports arm inks pact with Tanzania Port Authority for 30 year
  01-Jun-24   08:50
Back Top